Moelis & Company (MC) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary and Q&A indicate strong financial health with no debt and significant cash reserves, a positive outlook for M&A and capital markets, and strategic growth in PCA. Despite some general responses in the Q&A, the overall sentiment is positive due to expected record capital market performance, strategic hiring, and a $300 million buyback plan. The positive guidance and business expansion plans outweigh the lack of specific details in some areas, leading to a likely positive stock price movement.
Key Financial Performance
Fourth Quarter Revenues $488 million, an increase of 11% versus the prior year period. This growth was driven by year-over-year increases in M&A and capital markets, partially offset by a decline in capital structure advisory.
Full Year Adjusted Revenues $1.54 billion, an increase of 28% year-over-year. This growth was driven by 35% growth in M&A, a record-setting year for capital markets business, and double-digit increases in both average fees and number of completed transactions.
Adjusted Compensation Expense Ratios 61.1% for the fourth quarter and 65.8% for the full year, down from 69% last year. This improvement highlights meaningful operating leverage.
Adjusted Non-Compensation Expenses $60 million for the fourth quarter, resulting in a 12.4% non-compensation expense ratio. For the full year, adjusted non-compensation expenses were $224 million, resulting in a non-compensation expense ratio of 14.6%, down from 15.9% in the prior year. The main drivers of expense growth were increased deal-related T&E and client conferences, investments in technology and data, and higher occupancy costs due to headcount growth.
Adjusted Pretax Margin 28.6% for the fourth quarter and 21.5% for the full year 2025, representing 510 basis points of improvement from a 16.4% adjusted pretax margin in 2024. This improvement was due to revenue growth and reductions in both compensation and non-compensation expense ratios.
Adjusted EPS $2.99 per share for full year 2025, representing an increase of 64% from $1.82 per share in 2024. This was driven by revenue growth and reductions in expense ratios.
Capital Return to Shareholders $284 million for the 2025 performance year through dividends, net settlement of shares, and open market repurchases. This includes repurchasing 716,000 shares in the fourth quarter at an average price of $62.96 per share.
Cash and Debt Position $849 million of cash and no debt, highlighting a strong balance sheet.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Private Capital Advisory (PCA) Business: Substantial investment in 2025 led to meaningful traction. PCA team is integrated with industry and financial sponsor bankers. Secondaries pipeline is developing rapidly. Two new Managing Directors are joining, bringing the total to 7 MDs dedicated to GP-led secondaries.
M&A Growth: Revenues driven by 35% growth in M&A, including notable transactions like Netflix's acquisition of Warner Bros., Allied Gold's sale to Zijin Gold, and Ventyx Biosciences' sale to Eli Lilly.
Capital Markets Expansion: Record-setting year for capital markets business. Increased investor appetite across growth-oriented sectors in public and private markets.
Revenue Growth: Record fourth quarter revenues of $488 million. Full-year adjusted revenues grew 28% to $1.54 billion.
Operational Efficiency: Adjusted compensation ratio improved by 320 basis points to 65.8%. Non-compensation expense ratio decreased to 14.6% from 15.9%.
Technology Investments: Continued investments in technology and data, including AI, to support operations.
Strategic Hiring: Added 21 Managing Directors in 2025, including 9 lateral hires. Promoted 13 professionals to Managing Director in early 2026, bringing the total MD count to 178.
Capital Return Strategy: Increased share buybacks in Q4, repurchasing 716,000 shares. Total capital returned to shareholders in 2025 was $284 million. New $300 million share repurchase program authorized.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Capital Structure Advisory: Decline in capital structure advisory revenues, indicating potential challenges in this area of the business.
Leverage Across Companies: Significant leverage across many companies, compounded by accelerating technology disruption, could lead to more traditional restructurings and liability management challenges.
Non-Compensation Expenses: Increased deal-related travel and entertainment (T&E), client conferences, technology and data investments, and higher occupancy costs due to headcount growth, which may pressure expense management.
Economic and Market Conditions: Dependence on constructive financing markets and strong equity market performance, which are subject to economic uncertainties and market volatility.
Private Capital Advisory Growth: Substantial investment in private capital advisory business, which may face risks if the GP-led secondary market does not continue to grow as anticipated.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Active transaction environment in 2026: Constructive financing markets and strong equity market performance are setting the stage for an active transaction environment in 2026.
M&A activity trends: The breadth and depth of M&A activity seen at the end of 2025 is expanding and accelerating. Strategics are becoming more active with larger transformational deals, and sponsor activity is building as valuation alignment improves.
Capital Markets growth: Increased investor appetite across growth-oriented sectors is benefiting the team, with strong capabilities in both public and private markets.
Capital structure advisory outlook: A long runway of liability management assignments is expected due to significant leverage across companies and accelerating technology disruption. Traditional restructurings are anticipated over time as prior out-of-court solutions run their course.
Private Capital Advisory (PCA) growth: The PCA business is gaining traction, with a rapidly developing secondaries pipeline and additional Managing Directors joining in 2026. PCA is expected to become an increasingly important fourth pillar of the firm.
Non-compensation expenses in 2026: Non-compensation expenses are anticipated to grow at a similar rate to 2025 due to ongoing investments in technology, increased deal activity, and headcount growth.
Pipeline and business outlook: The business outlook is positive with a near-record pipeline, and the firm is confident in its ability to drive growth, generate operating leverage, and deliver sustained value over the long term.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Quarterly Dividend: The Board declared a regular quarterly dividend of $0.65 per share.
Total Capital Returned via Dividends: For the 2025 performance year, $284 million of capital was returned to shareholders through dividends, net settlement of shares, and open market repurchases.
Share Buyback Activity: During the fourth quarter, 716,000 shares were repurchased in the open market at an average price of $62.96 per share, bringing total repurchases for the year to approximately 950,000 shares.
New Share Repurchase Program: The Board authorized a new share repurchase program of up to $300 million with no expiration date.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What is the broader advisory outlook for Moelis, particularly regarding sponsor deals?
A:Moelis experienced a good year in 2025 with 28% year-over-year growth. Sponsor deals showed increasing velocity, but there is still room for growth before reaching equilibrium between capital return and deployment. The financing markets and broader economy are favorable, and Moelis is well-positioned to capitalize on GP-led secondaries and sponsor coverage in 2026.
Q:What is the base case for restructuring liability management activity?
A:There is a long runway of companies with balance sheets that are misaligned with their earnings. Technology disruption will impact sectors, leading to more liability management exercises and in-court restructuring assignments. Moelis has bolstered its creditor-side capabilities and expects flat to up performance in its CSA business for 2026.
Q:What is the outlook for M&A composition in 2026 and beyond?
A:Large-cap M&A transactions are expected to continue due to motivations for scale, efficiency, and technology adaptation. Middle-market deals, which have been muted, are expected to increase as financing costs stabilize and private equity firms face pressure to monetize portfolio companies.
Q:How is the geopolitical backdrop affecting M&A activity?
A:Geopolitical uncertainty is always a factor, but boards are becoming more accustomed to it. Unless there is a significant geopolitical shock, companies are focusing on positioning themselves for technology changes and equity value creation.
Q:What is the expected cadence of revenue recognition for Moelis in 2026?
A:Revenues are expected to be more back-half weighted in 2026, with a constructive environment for transactions and all-time highs in new business generation and pipeline activity.
Q:What is the outlook for compensation ratios in 2026?
A:Moelis aims to bring the compensation ratio below 65.8%, depending on revenue performance, banker pay competition, and hiring opportunities. The firm is committed to balancing growth with prudent cost management.
Q:How is AI disruption impacting M&A and liability management?
A:AI disruption is accelerating M&A activity in some sectors while potentially leading to liability management opportunities in others, such as software. Moelis is monitoring these trends and engaging with clients to navigate the changes.
Q:What is the timeline for the PCA build-out?
A:The PCA business is ramping as expected, with strong client reception and mandate wins. Significant revenue growth is anticipated in 2026 and beyond.
Q:How does Moelis approach hiring and competition for talent?
A:Moelis prioritizes hiring uniquely talented individuals who fit the firm's culture. The firm is opportunistic in hiring, even in a competitive market, to ensure long-term growth and client service.
Q:What is the significance of software and IT services in Moelis' sponsor franchise?
A:Software and IT services are significant sectors for Moelis, supported by a strong technology franchise and sponsor relationships. The firm is well-positioned to offer versatile solutions across M&A, capital markets, and liability management.
Q:What is the status of MD ramp-up at Moelis?
A:About one-third of MDs have been on the platform for less than three years, and one-fourth for less than two years. The firm is maturing into its talent base, with the most productive years for these MDs ahead.
Q:What are the trends in PCA business revenues?
A:The PCA business is still ramping, with most activity focused on winning new mandates. Significant revenue contributions are expected in 2026.
Q:What is the plan for the $300 million buyback authorization?
A:Moelis prioritizes maintaining its dividend, mitigating share dilution, and keeping a strong balance sheet. The timing of buybacks will depend on excess cash and strategic needs.
Q:How is Moelis positioned in a deregulatory environment?
A:Moelis competes effectively against both bulge bracket and independent firms. The firm sees momentum in its client base and continues to gain market share in its part of the market.
Q:What is the expected starting compensation ratio for 2026?
A:The starting compensation ratio for 2026 is expected to be similar to the 2025 year-end ratio of 65.8%, with adjustments likely in later quarters based on activity levels.
Q:Review of Unclear Management Responses
A:Management avoided providing specific predictions for the PCA revenue trajectory in 2026, the exact timing of the $300 million buyback authorization, and the starting compensation ratio for 2026. Additionally, responses to questions about geopolitical impacts and AI disruption were somewhat general, lacking detailed data or examples.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Abdullah Economic
Allied Gold
Boards confidence
Bros Allied
City Energy
Co Founder
Commerce debt
Department Commerce
Director afternoon
Director credit
Earth Department
Economic City
Eli Lilly
GP
MD
Managing Director
Moelis Full
PCA
ability
afternoon Moelis
breadth
director
leverage
momentum
number transaction
position
record level
sale
secondary
sponsor client
MC Transcript
Moelis & Company (MC) Q4 2025 Earnings Call Transcript
Positive2-4
The earnings call summary and Q&A indicate strong financial health with no debt and significant cash reserves, a positive outlook for M&A and capital markets, and strategic growth in PCA. Despite some general responses in the Q&A, the overall sentiment is positive due to expected record capital market performance, strategic hiring, and a $300 million buyback plan. The positive guidance and business expansion plans outweigh the lack of specific details in some areas, leading to a likely positive stock price movement.
Moelis & Company (MC) Presents at Goldman Sachs 2025 U.S. Financial Services Conference Transcript
Neutral12-9
Moelis & Company (MC) Q3 2025 Earnings Call Transcript
Positive10-29
The earnings call summary and Q&A reveal strong financial performance, strategic expansion, and positive market conditions. Record revenues and a healthy transaction environment indicate robust growth potential. The company's focus on scaling its PCA franchise and expanding in technology and business services sectors is promising. While some uncertainties exist, such as the impact of AI and regulatory nuances, they are not seen as immediate threats. Overall, the positive elements outweigh the negatives, suggesting a likely positive stock price movement.
Moelis & Company (MC) Q2 2025 Earnings Call Transcript
Positive7-24
The earnings call summary indicates a stable financial position with no debt and consistent tax rates. The Q&A reveals optimism about market conditions, a strategic focus on high-growth areas, and potential shareholder returns through stock repurchases. While there are some uncertainties in specific hiring plans, the overall sentiment from management and analysts is positive, especially with the potential for growth in the private capital advisory business. These factors suggest a likely positive stock price movement over the next two weeks.
MC Slides
MC Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
